
Joint Venture and Patent Grant Mark Jointechlabs’ Entry Into China Regenerative Medicine Microfat Market
Jointechlabs has been granted a core Chinese patent and has entered into a joint venture to develop the microfat market in China.
Read moreJointechlabs has been granted a core Chinese patent and has entered into a joint venture to develop the microfat market in China.
Read moreJointechlabs has released new components and standardized processing to reduce time, complexity, and cost of microfat-based regenerative medicine procedures.
Read moreNew syringes and a choice of cannulas will make adipose processing faster and personalized to each physician’s needs.
Read more